Navigation Links
NIH grants enable energy studies
Date:11/19/2007

Robert G. Kranz, Ph.D., professor of biology in Arts & Sciences, has been awarded two grants from the National Institutes of Health (NIH) to study pathways in bioenergy conversion. One is a long-term NIH R01 renewal titled "Cytochrome c Biogenesis", and it is for $1,203,250. It started on August 1. The renewal award means that NIH has funded Kranz continuously for 22 years.

The U.S. Department of Agriculture, U.S. Department of Energy, National Science Foundation and Monsanto also have supported the Kranz group during the past twenty years.

Cytochrome c is a protein with the heme cofactor covalently attached to it. Cytochrome c is crucial for energy production in many bacteria and higher organisms, including humans and it is one of the most rigorously researched cellular components over the past 60 years. It is essential for the production of ATP (adenosine triphosphate), the compound that energizes all organisms.

The road the cell takes to make cytochrome c is called the biogenesis pathway. There are three different pathways which organisms use to assemble a c-type cytochrome, and in a 1998 review Kranz and colleagues termed these "systems I, II, and III." Kranz discovered the most complex one, called System I, and published the results of genetic studies beginning in 1989. These results described many of the genes required for the system I pathway.

Current members of the Kranz group include Cindy Richard-Fogal, Ph.D., research scientist in biology, and Elaine Frawley who have engineered two of the three biogenesis pathways in E. coli. Now they will engineer the third, which is naturally present in humans. Additionally the function and mechanisms behind each protein in the pathways will be studied.

The second NIH grant, an R21 award of $190,000, is to further develop a screen to find inhibitors of the pathways. Since bacteria have either system I or II but humans do not, inhibitors could be potential antim
'/>"/>

Contact: Tony Fitzpatrick
tony_fitzpatrick@wustl.edu
314-935-5272
Washington University in St. Louis
Source:Eurekalert

Page: 1 2 3

Related biology news :

1. Homeland Security awards 2 grants to Rutgers for nuclear threat detection
2. Flu vaccine in painless skin patches under development at Emory, Georgia Tech with NIH grants
3. AACR, BCRF award inaugural grants in translational breast cancer research
4. Einstein researchers receive grants totaling $700,000 for innovative breast cancer research
5. NIH grants $33 M in institutional development awards to 3 states
6. Biometrics Help Identify, Apprehend and Deter Illegal Migrants
7. Carnegie Mellon scientists develop nanogels that enable controlled delivery of carbohydrate drugs
8. Thumb-size microsystem enables cell culture and incubation
9. High blood pressure, low energy -- a recipe for heart failure
10. Adding up renewable energy
11. Coal and black liquor can produce energy from papermaking

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/23/2009)...RE, Calif. - By producing some of the highest reso...faces, scientists have a deeper understanding how ...research may lead to a new treatment for kidney st...ppears in the Nov. 23 online edition of the journa... , explores how peptides interact with mineral sur...
(Date:11/23/2009)...MINGHAM, Ala. A new study by University of Alabam...mass index (BMI) and co-existing medical condition...ival observed among African-Americans compared to ...s published online Nov. 23 in Cancer , a journal ...dicates that although BMI and co-morbidity are ind...
(Date:11/23/2009)...GN, Ill. Two new studies reveal in unprecedented ...ules to assemble new proteins and guide them towar...es used molecular dynamics flexible fitting (MDFF)...wo prominent molecular partners. , The first st...iences , concerns the intimate signaling between t...
Breaking Biology News(10 mins):Scientists watch as peptides control crystal growth with 'switches, throttles and brakes' 2Scientists watch as peptides control crystal growth with 'switches, throttles and brakes' 3Racial disparity in colon cancer survival not easily explained, UAB researchers say 2Computational microscope peers into the working ribosome 2Computational microscope peers into the working ribosome 3Kensey Nash Announces Agreement to Acquire Rights to OsseoFit Product 13449 1Kensey Nash Announces Agreement to Acquire Rights to OsseoFit Product 13449 2Kensey Nash Announces Agreement to Acquire Rights to OsseoFit Product 13449 3Catalyst Pharmaceutical Partners Reports Second Quarter 2009 Financial Results 13447 1Catalyst Pharmaceutical Partners Reports Second Quarter 2009 Financial Results 13447 2Catalyst Pharmaceutical Partners Reports Second Quarter 2009 Financial Results 13447 3Catalyst Pharmaceutical Partners Reports Second Quarter 2009 Financial Results 13447 4Catalyst Pharmaceutical Partners Reports Second Quarter 2009 Financial Results 13447 5Catalyst Pharmaceutical Partners Reports Second Quarter 2009 Financial Results 13447 6Catalyst Pharmaceutical Partners Reports Second Quarter 2009 Financial Results 13447 7Warner Chilcott Reports Operating Results for the Quarter Ended June 30 2009 and Updates 2009 Full Year Guidance 53933 1Warner Chilcott Reports Operating Results for the Quarter Ended June 30 2009 and Updates 2009 Full Year Guidance 53933 2Warner Chilcott Reports Operating Results for the Quarter Ended June 30 2009 and Updates 2009 Full Year Guidance 53933 3Warner Chilcott Reports Operating Results for the Quarter Ended June 30 2009 and Updates 2009 Full Year Guidance 53933 4Warner Chilcott Reports Operating Results for the Quarter Ended June 30 2009 and Updates 2009 Full Year Guidance 53933 5Warner Chilcott Reports Operating Results for the Quarter Ended June 30 2009 and Updates 2009 Full Year Guidance 53933 6Warner Chilcott Reports Operating Results for the Quarter Ended June 30 2009 and Updates 2009 Full Year Guidance 53933 7Warner Chilcott Reports Operating Results for the Quarter Ended June 30 2009 and Updates 2009 Full Year Guidance 53933 8Warner Chilcott Reports Operating Results for the Quarter Ended June 30 2009 and Updates 2009 Full Year Guidance 53933 9Warner Chilcott Reports Operating Results for the Quarter Ended June 30 2009 and Updates 2009 Full Year Guidance 53933 10Warner Chilcott Reports Operating Results for the Quarter Ended June 30 2009 and Updates 2009 Full Year Guidance 53933 11Warner Chilcott Reports Operating Results for the Quarter Ended June 30 2009 and Updates 2009 Full Year Guidance 53933 12Warner Chilcott Reports Operating Results for the Quarter Ended June 30 2009 and Updates 2009 Full Year Guidance 53933 13Warner Chilcott Reports Operating Results for the Quarter Ended June 30 2009 and Updates 2009 Full Year Guidance 53933 14Warner Chilcott Reports Operating Results for the Quarter Ended June 30 2009 and Updates 2009 Full Year Guidance 53933 15Warner Chilcott Reports Operating Results for the Quarter Ended June 30 2009 and Updates 2009 Full Year Guidance 53933 16Warner Chilcott Reports Operating Results for the Quarter Ended June 30 2009 and Updates 2009 Full Year Guidance 53933 17Warner Chilcott Reports Operating Results for the Quarter Ended June 30 2009 and Updates 2009 Full Year Guidance 53933 18
...veal where a brain cell came from remain distinct ...rnational coalition of scientists will report in t...ding adds a new layer of complexity to the quest t..., according to senior author David H. Gutmann, M.D...f Neurology at Washington University School of Med...
...he risk of HIV transmission may be highest in the ...ublished in the April 1 issue of The Journal of In...ection accounted for nearly half of all transmissi...e province of Quebec, Canada. , Bluma Brenner, PhD...e in Montreal, and colleagues from several hospita...
...e noise, says a team of Rutgers-Camden professors ...he benefits of noise. Their findings could lead to...awei Hong, an assistant professor of computer scie...lliam Saidel, an associate professor of biology, a...fits of noise through mathematics. Although the Ru...
Other Biology News:Genetic fingerprints identify brain tumors' origins 2Risk of HIV transmission highest early in infection 2Noise echoes in cell communications 2
(Date:11/24/2009)...arbleEnergyCorp.announcedtodaythatthecompanyandthe...awarded$2millionbyWashingtonState,sCommunityEconom...rshiptoconstructthestate,sfirstspecialtybiochemica...entwillsignificantlyspeedthedevelopmentofourbioref...lueMarbleEnergyCEOKellyOgilvie."Wearegratefultothe...
(Date:11/24/2009)...tCall/--Shireplc(LSE:SHP,NASDAQ: SHPGY ),thegloba...thatithassubmittedaMAAtotheEuropeanMedicinesAgency...ttherapyindevelopment,forthetreatmentofType1Gauche...aglucerasealfathathasbeensubmitted,withprevious,su...naglobalsupplyshortageofthecurrentlyapprovedandmar...
(Date:11/24/2009)...s Customers with Partners Validated to Process and...ts , Ottawa, ON (PRWEB) N...der of products for biological sample collection, ... new global partner program. The program offers si...ommunity and is designed to help partners scale an...
(Date:11/23/2009)... origami very high-tech origami. , Researchers a...nique for fabricating three-dimensional, single-cr...upling photolithography and a self-folding process...nly a few microns thick, offer mechanical bendabil...e same material. , "This is a completely differen...
Breaking Biology Technology:Blue Marble Energy, OPDA Awarded $2M by WA's Community Economic Revitalization Board 2Shire Submits European Marketing Authorization Application (MAA) for velaglucerase alfa for the Treatment of Type 1 Gaucher Disease 2Shire Submits European Marketing Authorization Application (MAA) for velaglucerase alfa for the Treatment of Type 1 Gaucher Disease 3DNA Genotek Launches Global Partner Program 2DNA Genotek Launches Global Partner Program 3Water droplets direct self-assembly process in thin-film materials 2
... (Nasdaq: DCTH ) today announced the appointment...rectors. Dr. Stoll is Executive Chairman of Corte...ology company specializing in the treatment of cen... http://www.newscom.com/cgi-bin/prnh/20081118/NY46...toll worked as a consultant to several east coast ...
...orporation,(Nasdaq: PRXL ), a leading global bio...hat it has established an alliance with Safe Imple...onal, the world,s largest network of,clinical site...oke. Through,this alliance, PAREXEL,s clients bene...r sites located in 40 countries, which are dedicat...
...armaceuticals Ltd. (Nasdaq: XTLB ; TASE: XTL) an...ons following the failure of the Bicifadine Phase ...employment of 9 employees,representing 75% of its ...sible for seeking potential assets or a company to...on and/or disposition of XTL,s assets. , Cau...
Other Biology Technology:Delcath Adds Senior Pharmaceutical Professional to Its Board of Directors 2Delcath Adds Senior Pharmaceutical Professional to Its Board of Directors 3PAREXEL Establishes Alliance with SITS Network of Clinical Sites Specializing in Stroke Studies 2PAREXEL Establishes Alliance with SITS Network of Clinical Sites Specializing in Stroke Studies 3PAREXEL Establishes Alliance with SITS Network of Clinical Sites Specializing in Stroke Studies 4
... a base medium for preparation of minimal and synt...ulfate but does not contain amino acids. Both bulk... Each pouch contains reagents to prepare 500 ml of...r S. cerevisiae media. Store at 15C to 30C. Guaran...
...ons are cytopathic effect inhibition assays, also ...tion assay measures the antibody's ability to neut...pes include; tissue culture supernatents; serum an...t is defined as the quantity of interferon require...
Rabbit Anti-Shigella Polyclonal Antibody, Unconjugated from GeneTex
...dy is a mouse monoclonal antibody (IgG1) with high...(GST) domain from S. japonicum . This purified ant...ntaining the GSTTag sequence expressed in E. coli ...nslation systems by Western blotting, immunofluore...
Biology Products: